Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Equivalent Oral Prednisone Dosing When Switching from IV Methylprednisolone

Conversion Guidelines

  • The American Academy of Otolaryngology-Head and Neck Surgery recommends a 1:1.25 ratio when converting from intravenous (IV) methylprednisolone to oral prednisone, meaning 1 mg of IV methylprednisolone is equivalent to 1.25 mg of oral prednisone 1, 2
  • For standard conversion from IV methylprednisolone to oral prednisone, 40 mg IV methylprednisolone is equivalent to 50 mg oral prednisone, and 80 mg IV methylprednisolone is equivalent to 100 mg oral prednisone 3
  • When converting from high-dose pulse IV methylprednisolone therapy (250-1000 mg/day) to oral maintenance therapy, start with prednisone 0.5-1 mg/kg/day orally 4, 5
  • For severe conditions, up to 1-2 mg/kg/day of prednisone may be required initially 1, 6

Relative Potency of Different Corticosteroids

  • Methylprednisolone is 5 times more potent than hydrocortisone, and prednisone is 4 times more potent than hydrocortisone 3
  • Dexamethasone is 25 times more potent than hydrocortisone, and therefore, 48 mg methylprednisolone is equivalent to 60 mg prednisone and 10 mg dexamethasone 3

Clinical Applications

  • For immune-related adverse events (irAEs), grade 2 can be treated with IV methylprednisolone 0.5-1 mg/kg/day, which can be converted to oral prednisone 0.5-1 mg/kg/day, and grade 3-4 can be treated with IV methylprednisolone 1-2 mg/kg/day, which can be converted to oral prednisone 1-2 mg/kg/day 1, 6
  • For lupus nephritis, after IV pulse methylprednisolone (500-2500 mg total dose), transition to oral prednisone 0.3-0.5 mg/kg/day 7
  • For pemphigus vulgaris, after IV methylprednisolone pulse (250-1000 mg/day for 2-5 days), transition to oral prednisone 0.5-1 mg/kg/day 4, 5

Important Considerations

  • When tapering from high-dose therapy, taper oral prednisone over 4-6 weeks after achieving disease control, and for autoimmune conditions, consider a slower taper below 20 mg/day 1, 6, 8, 9
  • Common pitfalls to avoid include underdosing when converting, failing to adjust for different bioavailability, and not considering patient-specific factors like disease severity and comorbidities 3, 4, 8

Adverse Effects Considerations

  • Higher initial oral glucocorticoid doses are associated with more serious adverse events, and short courses (7-14 days) usually have manageable adverse events, with hyperglycemia and weight gain being most common 3
  • Consider prophylaxis for GI protection with proton pump inhibitors when using high-dose steroids, and add PCP prophylaxis if immunosuppression with >30 mg prednisone or equivalent is expected for more than 3 weeks 1, 6

REFERENCES

3

clinical practice guideline: sudden hearing loss. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2012